Amniotic fluid and tissue therapy is emerging as one of the newest innovations in orthopedics and sports medicine. Amniotic tissue is derived from the human amniotic membrane, the cover or membrane that surrounds the developing fetus in utero. The recovery of the membrane does not affect the baby or the delivery process. Therefore, the donation process does not share the same ethical concerns associated with embryonic tissue. Amniotic tissue is one of the richest known sources of growth factors. Growth factors are powerful molecules that our bodies produce to signal cells to migrate to a target site, help the site to heal, and influence the body’s own cells to regenerate damaged tissue. There are over 200 different growth factors, specialized cytokines, and enzyme inhibitors identified in amniotic tissue, including Transforming Growth Factor Beta (TGF-B), Fibroblast Growth Factor (FGF), Platelet-Derived Growth Factor (PDGF), and Human Growth Factor (HGH).
More information on “Amnio” injections coming soon. If you think you might be a candidate, contact Dr. Dold for a consultation.